NCT04288323View on ClinicalTrials.gov

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) Vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients with Cirrhosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 27, 2018

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Liver CancerLiver CirrhosesLiver Carcinoma
Interventions
DRUG

Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid

This study involves an on-label use of Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid for the ....

Trial Locations (1)

92037

RECRUITING

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

INDUSTRY

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

University of California, San Diego

OTHER